Skip to main content
. Author manuscript; available in PMC: 2015 Jul 1.
Published in final edited form as: Circulation. 2014 May 2;130(1):27–34. doi: 10.1161/CIRCULATIONAHA.113.008285

Figure 1.

Figure 1

Current HGPS treatment strategies aimed at preventing formation of progerin protein by inhibiting post-translational farnesylation of preprogerin. Enzymes facilitating each step are italicized. Dashed line indicates multiple steps in pathway not shown. Medications aimed at inhibiting protein farnesylation are circled. ICMT = isoprenylcysteine carboxyl methyltransferase